Thyroid hormone may drive prostate cancer

Thyroid hormone receptor beta signalling is a targetable driver of prostate cancer growth. An international research team led by the Medical University of Vienna has...

Registration is now open for VyvaExperts25

Global oncology and vascular access experts unite this October to advance cancer care Vygon's VyvaExperts25 to spotlight innovation and best practice in vascular access Registration...

Early diagnosis of less survivable cancers

Early diagnosis of less survivable cancers could save 7,500 lives annually.  The All-Party Parliamentary Group (APPG) on Less Survivable Cancers has released a pivotal report urging...